title: Anti-TNF-α agents and serum lipids in inflammatory bowel diseases.
authors: Faculty of Medicine, Ankara University, Department of Gastroenterology, Ibn-iSina Hospital, Sihhiye, 06100 Ankara, Turkey.
authors: Çağdaş
authors: Ç
authors: Kalkan
authors: Faculty of Medicine, Ankara University, Department of Gastroenterology, Ibn-iSina Hospital, Sihhiye, 06100 Ankara, Turkey.
authors: Fatih
authors: F
authors: Karakaya
authors: Faculty of Medicine, Ankara University, Department of Gastroenterology, Ibn-iSina Hospital, Sihhiye, 06100 Ankara, Turkey.
authors: Murat
authors: M
authors: Törüner
authors: Faculty of Medicine, Ankara University, Department of Gastroenterology, Ibn-iSina Hospital, Sihhiye, 06100 Ankara, Turkey.
authors: Hülya
authors: H
authors: Çetinkaya
authors: Faculty of Medicine, Ankara University, Department of Gastroenterology, Ibn-iSina Hospital, Sihhiye, 06100 Ankara, Turkey. Electronic address: isoykan@medicine.ankara.edu.tr.
authors: Irfan
authors: I
authors: Soykan
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood / Q000188:drug therapy*; D000069285:Infliximab / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D008297:Male; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D005765:Gastrointestinal Agents; D008055:Lipids; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab